Articles in section Licensing
| << Joint Venture | 505 articles | Mergers & Acquisitions >> |
| Pages 1 2 3 4 5 .. 51 | Next >> |
-
Moderna Signs US$1.8 B Oncology Collaboration with Immatics
-
Immunogen Collaborates with Takeda to Develop and Commercialise Elahere® in Japan
-
Agios signs US$147.5 M License Deal with Alnylam’s RNAi therapeutic for Polycythemia Vera
-
Lilly’s Prevail Signs Gene Editing Collaboration with Scribe Therapeutics for Neurological Diseases
-
Janssen Signs Collaboration and License Agreement with Cellular Biomedicine to Develop CAR-T Therapies
-
Pipeline Therapeutics Signs Licensing Agreement with Janssen for Investigational Neurotherapeutic, PIPE-307
-
Bristol Myers Squibb Signs US$1 B+ Deal with Tubulis for Solid Tumour ADCs
-
BioNTech Enters ADC Field with US$1.6 B+ DualityBio Licensing Deal
-
ImmunoGen Signs Partnership with Vertex for Conditioning Agents worth US$352 M
-
Eli Lilly Licenses Non-Opioid Pain Drug from Confo Therapeutics
RSS